Laurence Lagarce
Overview
Explore the profile of Laurence Lagarce including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
135
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bourneau-Martin D, Grandvuillemin A, Babin M, Mullet C, Said H, Cellier M, et al.
Eur J Hosp Pharm
. 2024 Apr;
PMID: 38621957
Objectives: Drug shortages are of increasing concern to worldwide public health. The consequences of drug shortages for patient safety have been little studied, especially from a pharmacovigilance point of view....
2.
Cellier M, Bourneau-Martin D, Abbara C, Crosnier A, Lagarce L, Garnier A, et al.
Cancers (Basel)
. 2023 Apr;
15(7).
PMID: 37046701
Background: Alongside their BCR-ABL specificity, TKIs used in chronic myeloid leukemia also target other tyrosine kinases expressed in the kidney such as PDGFR, c-KIT, SRC, and VEGFR, which may result...
3.
Emonet C, Tetart F, Bauvin O, Cellier L, Courville P, Mignard C, et al.
J Immunother
. 2023 Jan;
46(2):59-63.
PMID: 36622668
Immune checkpoint inhibitors (ICIs) have become the standard treatment for many types of cancer. After several years of using these therapies, many adverse events related to ICIs have been observed....
4.
Bourneau-Martin D, Babin M, Grandvuillemin A, Mullet C, Salvo F, Singier A, et al.
Br J Clin Pharmacol
. 2022 Sep;
89(3):1080-1088.
PMID: 36177609
Aim: Drug shortages are a growing global health issue. The aim of the study was to evaluate the consequences of drug shortages on patient safety based on data recorded in...
5.
Laroche M, Gautier S, Polard E, Rabier M, Chouchana L, Lebrun-Vignes B, et al.
Br J Clin Pharmacol
. 2022 Aug;
89(1):390-400.
PMID: 36002314
Aims: In the last French study in 2007, the incidence of hospital admissions (HAs) related to adverse drug reactions (ADRs) was 3.6%. The objective was to assess the current ADR-HA...
6.
Garnier A, Lagarce L, Augusto J
J Nephrol
. 2022 Jan;
35(3):1015-1016.
PMID: 35094373
No abstract available.
7.
Crosnier A, Abbara C, Cellier M, Lagarce L, Babin M, Bourneau-Martin D, et al.
Cancers (Basel)
. 2021 Dec;
13(23).
PMID: 34885014
Kidney EGFR expression together with reported cases of glomerular diseases in the context of anti-EGFR drug administration raise concerns about the renal safety profile of these drugs. This issue is...
8.
Vincent L, Bourneau-Martin D, Maurier A, Babin M, Delepine S, Helley D, et al.
Therapie
. 2021 Mar;
76(6):687-693.
PMID: 33726948
Background: Abciximab (ABX) is used for acute coronary syndrome and unstable angina. Thrombocytopenia is a frequent adverse effect described as occurring in the first 24hours. The aim of this study...
9.
Yvin E, Beloncle F, Thepot S, Lagarce L, Augusto J, Garnier A
Therapie
. 2020 Sep;
76(5):498-499.
PMID: 32919761
No abstract available.
10.
Garnier A, Dellamaggiore J, Brilland B, Lagarce L, Abgueguen P, Furber A, et al.
J Clin Med
. 2020 Jul;
9(7).
PMID: 32605085
Background: Amoxicillin (AMX)-induced crystal nephropathy (AICN) is considered as a rare complication of high dose intravenous (IV) AMX administration. However, recently, its incidence seems to be increasing based on French...